Loading organizations...
Loading organizations...
Biotech company developing small molecule drugs for hearing loss treatment.
Acousia Therapeutics has raised $14.6M across 2 funding rounds.
Acousia Therapeutics has raised $14.6M in total across 2 funding rounds.
Acousia Therapeutics has raised $14.6M in total across 2 funding rounds.
Acousia Therapeutics's investors include Harald Poth, Frank Kalkbrenner, Bregua Corporation, KfW, Boehringer Ingelheim, Stefan Lohmer.
Acousia Therapeutics has raised $14.6M across 2 funding rounds. Most recently, it raised $11.9M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 14, 2018 | $11.9M Series B | Harald Poth | Frank Kalkbrenner, Bregua Corporation, KfW |
| Dec 16, 2016 | $2.6M Other Equity | Boehringer Ingelheim | Stefan Lohmer, KfW |